Continuous outcome measures: conundrums and conversions contributing to clinical application.

A new interesting article has been published in BMJ Evid Based Med. 2019 Aug;24(4):133-136. doi: 10.1136/bmjebm-2018-111136. Epub 2019 Mar 5. Comment and titled:

Continuous outcome measures: conundrums and conversions contributing to clinical application.

Authors of this article are:

Mayer M.

A summary of the article is shown below:

Many patient-relevant outcomes, particularly quality of life measures such as pain or function, are routinely measured on a continuous scale. However, the interpretation of continuous outcomes is difficult, particularly when considering application to clinical practice and shared decision-making. Making matters worse is the frequent existence of multiple scales for any given construct. Therefore, quantitative syntheses of literature must find a way to combine different scales into a ‘common language’, and the most frequently used and longest-standing method to do so is the standardised mean difference. Unfortunately, the standardised mean difference is even more difficult to interpret clinically. However, there are validated methods to make these measures easier to understand and apply clinically. This analysis explores these issues and offers a resource to help make these continuous measures more clinically useful.© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Check out the article’s website on Pubmed for more information:



This article is a good source of information and a good way to become familiar with topics such as: Epidemiologic Studies;Humans;Odds Ratio;Treatment Outcome.

New Chemicals from MOLECULAR DEPOT


New Proteins from MOLECULAR DEPOT


New Antibodies from MOLECULAR DEPOT


New Research Kits from MOLECULAR DEPOT

Molecular Depot

Your specialty peptide, proteins, antibodies and chemical compounds store.